Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap

Published:2018-08 Issue: Volume:Volume 12 Page:2371-2379
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Zhang Xiaoli,Chen Yuqing,Fan Liyu,Ye Jiaqi^ORCID,Fan Junsheng^ORCID,Xu Xinjie,You Danming,Liu Sihan,Chen Xin,Luo Peng^ORCID

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic treatment with phosphodiesterase-4 inhibitors alleviates kidney injury and renal fibrosis by increasing MMP-9 in a doxorubicin-induced nephrotoxicity mouse model;International Immunopharmacology;2023-02

2. Roflumilast Protects against Neuroinflammatory Alterations in Brain Tissues of Lipopolysaccharide-induced Mice Model;Current Alzheimer Research;2023-01

3. The immunomodulatory effects of roflumilast on tachyzoite-bradyzoite transition in a murine model of Toxoplasma gondii;International Immunopharmacology;2022-12

4. Transcriptome analysis of sputum cells reveals two distinct molecular phenotypes of “asthma and chronic obstructive pulmonary disease overlap” in the elderly;European Journal of Medical Research;2022-10-28

5. Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap;Immunology and Allergy Clinics of North America;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP